Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
Background: FOLFOX treatment is a method used widely to reduce tumor size in low-set rectal cancer, with variable clinical results. FOLFOX agents comprise a mixture of oxaliplatin and 5-fluorouracil, the efficacy of which might be modulated by the gut microbiome in humans. This study aimed to determ...
Saved in:
Main Authors: | Jing Li (Author), Jingtao Li (Author), Na Lyu (Author), Yue Ma (Author), Fei Liu (Author), Yuqing Feng (Author), Li Yao (Author), Zhiyong Hou (Author), Xiaofeng Song (Author), Hongchuan Zhao (Author), Xiaoya Li (Author), Yingdian Wang (Author), Cheng Xiao (Author), Baoli Zhu (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study on biotransformation and absorption of genistin based on fecal microbiota and Caco-2 cell
by: Zhe Li, et al.
Published: (2024) -
The brain-protective mechanism of fecal microbiota transplantation from young donor mice in the natural aging process via exosome, gut microbiota, and metabolomics analyses
by: Longfei Lin, et al.
Published: (2024) -
Next Generation Fecal Microbiota Transplantation
by: Tae-Geun Gweon, et al.
Published: (2021) -
Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer
by: Xiaoying Hou, et al.
Published: (2021) -
Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
by: Pufang Tan, et al.
Published: (2020)